Yes, but maraviroc, even if taken for 1- 2 weeks o
Post# of 148185
"Nevertheless, two cases of acute hepatocellular injury arose in patients receiving maraviroc in prelicensure clinical trials. Both were women, ages 24 and 27, who developed fever, fatigue and rash followed by liver tests abnormalities within 1 to 3 weeks of starting maraviroc."
https://www.ncbi.nlm.nih.gov/books/NBK548266/
Which is why any long-hauler taking it would need to be monitored very closely.
Therefore, BP shouldn't recommend it so carelessly on Twitter without stating risks more ckearly, though you can clearly see his frustration with LL not being approved yet...